Three insights:
1. Investors seem to fear that the government’s heightened concern about “surprise billing” could lower Nashville, Tenn.-based Envision’s revenues, according to a Financial Times analysis.
2. In late August, ratings agency Fitch placed KKR’s $5.4 billion loan on its list of “struggling” deals. The list takes into account a loan’s rating, its market price and adverse market information.
3. Envision’s $5.4 billion loan maturing in 2025 dropped from 86.2 cents on the dollar in early August to 77.3 cents on the dollar on Aug. 28.
“If revenues fall for the providers, then we could run into a cash flow problem with all of this debt,” Ron Launsbach, a senior portfolio manager at asset manager Columbia Threadneedle, told Financial Times. “Clearly there is uncertainty and that hurts the loan price because there aren’t many people wanting to buy the debt.”
Click here for the full Financial Times report.
More articles on surgery centers:
Dr. Nadja West joins Tenet board
Surgical Notes looking for RCM talent with an ASC focus
Surgery Partners’ former finance leader named CFO of behavioral health system: 3 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.